Science News Daily

(0:10): Sacituzumab Tirumotecan Boosts Survival in Endometrial Cancer; Merck Eyes Global Approval

(2:21): Rutgers Study Reveals Natural Pathways to Cooperation in Prisoner's Dilemma Without Kinship or Rules

(3:40): HistoSonics Gains Ground in Asia with TFDA Approval for Edison Histotripsy System

(5:24): Swedish Study Expands to Predict Autism, ADHD Trajectories with AI by Age 10

(7:54): GlucoBrain: Revolutionizing Diabetes-Dementia Research with 3D Microfluidic Biochip

To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.

Image credit: Rutgers University

What is Science News Daily?

Welcome to Science News Daily, brought to you by Brief! Our AI selects the latest stories and top headlines and then delivers them to you each day in less than ten minutes (for more details, visit www.brief.news/how-it-works). Tune in to get your daily news on fascinating topics, including physics, biology, chemistry, astronomy, and more. Whether you're a science enthusiast, researcher, or simply curious about the wonders of the natural world, this podcast is your ultimate source for all things science. Tune in daily to stay up-to-date with the latest scientific breakthroughs.

Want to get these updates by email? Subscribe to Brief today https://www.brief.news/